DAVID TYSINGER: Open Payments
NPI 1538317698 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,387 in 134 payments from 32 companies in 2025. Trend: 2023 $1,946 · 2024 $2,263 · 2025 $2,387
Food & beverage: $2,318Education: $69
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 13 | $266 |
| ViiV Healthcare Company | 16 | $248 |
| ABBVIE INC. | 11 | $208 |
| Abbott Laboratories | 11 | $200 |
| PFIZER INC. | 10 | $148 |
| Amgen Inc. | 11 | $139 |
| Novo Nordisk Inc | 10 | $138 |
| AstraZeneca Pharmaceuticals LP | 8 | $137 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $131 |
| Astellas Pharma US Inc | 1 | $69 |
Products named: FREESTYLE LIBRE 3, CABENUVA, Kerendia, AIRSUPRA, UBRELVY, NURTEC ODT, OTEZLA, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
